Previous 10 | Next 10 |
Three months into 2022, the markets are in turmoil, and highly priced stocks are falling fast. Investors can look for safety in value-oriented investments that are less vulnerable to sharp declines. The businesses listed here are all profitable and trading at incredibly cheap future earning...
MRK and MO might not seem like they go together too well, but the actual underlying business is what matters for an income investor. MRK has a steady business in the healthcare space, and MO has pricing power. They might originate from two different sectors and be quite opposites,...
SCHD's index both rebalances and reconstitutes its holdings the second Friday in March. SCHD has been adjusting to the recent reconstitution. It added 14 stocks. We look at EOG resources which was the largest new holding and at the sectors represented by the rest of the much smaller s...
Ireland-based self-care company, Perrigo Company (NYSE:PRGO), announced on Thursday that the U.S. Food and Drug Administration (FDA) granted the final approval for over-the-counter use of Nasonex 24HR Allergy. Perrigo (PRGO) identified the approval as its “first branded Rx-to-OTC switc...
Organon & Co. (OGN) 42nd Annual Cowen Health Care Conference March 09, 2022 09:10 AM ET Company Participants Kevin Ali - Chief Executive Officer Matthew Walsh - Chief Financial Officer Sandra Mulligan - Head, R&D Conference Call Participants Steve Scala - Cowen Michael Nedelcovych - C...
Shares of Organon & Co. (NYSE:OGN) traded today at $38.28, eclipsing its 52-week high. So far today approximately 390,000 shares have been exchanged, as compared to an average 30-day volume of 2.2 million shares. Organon & Co is a science-based global pharmaceutical company that ...
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Cowen 42 nd Annual Healthcare Virtual Conference on Wednesday, March 9, 2022 at 9:10 a.m. EST. Investo...
Organon (NYSE: OGN), a global women’s health company, today announced the appointment of Meghan Rivera as US Managing Director. With over 20 years of commercial experience in bio-pharmaceutical organizations and digital therapeutics, Ms. Rivera will be responsible for leading Org...
Viatris was formed by the merger of Pfizer's Legacy Brands business Upjohn with generic drug developer Mylan. Organon was formed after Merck spun out its Women's Health, biosimilars and legacy brands division to form a separate company. Both companies are strikingly undervalued ba...
Organon & Co. (OGN) Q4 2021 Results Conference Call February 17, 2022 08:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matt Walsh - CFO Conference Call Participants Jason Gerberry - Bank of America Chris Schott - JP Morgan Greg Fraser - Truist Securities Umer Raf...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...